In 2015, Sun Health initiated the FA service for China- EU life science M&A business.

In China, more than 150 Pharmas have close cooperation with us, like:

Fosun Pharma, Salubris Pharma, Wuxi AppTec, Luye Pharma, KPC Pharmaceuticals, BGI Genomics, China Medical System Holdings Limited, Wondfo Bio, Humanwell Healthcare, Huahai Pharmaceutical, CR Saike, Huapont Life Science, Chindex Medical, Kangmei Pharmaceuticals, Kangda International Medical, Weigao Group, TASLY, Innovative Medcare Technology, CP Pharmaceutical, Guangji Pharma, Shanghai Rass, Sanpower Group, Simcere Pharma, 3SBio Inc, Gloria Pharmaceutical, Yuwell Technology, Neusoft, Mayinglong Pharm, Menovo Pharmaceutical, Kinetic, Jumpcan Pharmaceutical, Livzon Pharmaceutical, Beilu Pharmaceutical, Chase Sun Pharma, Shuangcheng Pharmaceutical, Joincare, SHINVA Medical, China Resources Pharmaceutical, Huaren Pharmaceutical, DA AN Gene, Haisco Pharmaceutical, Kanghong Pharmaceutical, Porton Pharma, Yudong Health, Zhongheng Group, Qilu Pharma, China Meheco Group, Jiminkexin Pharmaceutical, Hosun Group.

More than 150 VC/PEs have close cooperation with us, like:

Yunfeng Capital, CDH Investments, China National Pharmaceutical Investment, Hermed Capital, Sequoia Capital，6 Dimensions Capital, Kaitai Capital, Warburg Pincus, 3E Bioventures, Cathay Capital, Northern Light VC, IDG Capital, Tsinghua Holdings Capital, MatrixPartners China, Sangel VC, Fortune Capital, Leading Capital, CH-GEMSTONE Capital, GTJA Investment, Kindem Invest, Hosen Healthcare Investment, E-house China Capital, Zhongzhi Industry Investment, Yuntai Fund, China Minsheng Investment, GSUM Capital, Yuexiu Financial Holding, ShangHai Pudong Science and Technology Investment, Huayi Capital, National Economy Capital, Jin Merchants Alliance, Sensegain Asset Management, Yueyin Asset Management, LYFE Capital, Citic PE, HH&E Venture, HG Capital, Hao Capital, Cenova Capital

Cooperation companies in DACH Region 

Pharma: cardiovascular and cerebrovascular drugs, cancer drugs, generic drugs, marketed drugs, dermatology drugs, severe infection，psychonosology, digestion drugs, chronic disease drugs, Ophthalmology drugs, radiopharmaceutical

Biotech: tumor immunotherapy（CAR-T, PD-1/PD-L1 etc）, IVD, POCT, herbal medicine, blood products, health/food products, IVF, gene sequencing/testing, cell therapy, diabetes drugs, vaccine, reproductive health products

MedTech: surgical robot, high-value consumables, innovative drug delivery technology,imaging diagnosis, orthopedic related products, dental related products, medical big data,